England's Cancer Drugs Fund 'failed to deliver meaningful value to patients and society'

(European Society for Medical Oncology) Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily from toxic side effects of the drugs. The review by Professor Richard Sullivan and Dr. Ajay Aggarwal is published in Annals of Oncology with an accompanying editorial by Dr. Kapil Dhingra.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news